Antipsychotic prescribing in care homes before and after launch of a national dementia strategy

An observational study (2015) in English institutions over a 4-year period | BMJ Open PDF Strengths and limitations of this study To our knowledge, this is the first UK study to examine long-term impact of a national policy initiative on antipsychotic prescribing in carehomes. The samples studied are many times those of other UK antipsychoticContinue reading “Antipsychotic prescribing in care homes before and after launch of a national dementia strategy”

Care homes: averting market failure in a post-covid-19 world

Jill Manthorpe and Steve Iliffe, BMJ, 18 January 2021 We need public and political consensus about long term options Our population is not ageing well. The proportion of older people affected by medium to high disability in England is increasing, but social care cannot meet their needs and seems curiously separate from the NHS. ItContinue reading “Care homes: averting market failure in a post-covid-19 world”